XML 44 R25.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

12 Months Ended

Dec. 31, 2022

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Net Income (Loss) Per Share

		For the Years Ended December 31,
		2022				2021
Net Income (Loss)		$	(2,880,060	)		$	(4,435,499	)
Net income (loss) attributable to common shareholders		$	(2,880,060	)		$	(4,435,499	)
Weighted average number of shares of common stock outstanding:
Basic			19,743,544				17,538,994
Diluted			19,743,544				17,538,994
Net income (loss) attributable to common shareholders per share:
Basic		$	(0.15	)		$	(0.25	)
Diluted		$	(0.15	)		$	(0.25	)

		For the Years Ended December 31,
		2022				2021
Numerator:
Net Income (Loss)		$	(2,880,060	)		$	(4,435,499	)
Denominator:
Basic weighted-average shares			19,743,544				17,538,994
Effect of dilutive securities
Warrants			-				-
Options			-				-
Preferred Stock			-				-
Diluted Weighted Average Shares			19,743,544				17,538,994
Net Income (Loss) Per Common Share:
Basic		$	(0.15	)		$	(0.25	)
Diluted		$	(0.15	)		$	(0.25	)

Note: Warrants, options and preferred stock for the years ended December 31, 2022 and 2021 are not included in the computation of diluted weighted average shares as such inclusion would be anti-dilutive.

Disaggregation of Revenue

		For The Years Ended December 31,								Change
		2022				2021
SteraMist Product		$	6,864,000			$	6,179,000			$	685,000
Service and Training			1,474,000				1,575,000				(101,000	)
Total		$	8,338,000			$	7,754,000			$	584,000

		For The Years Ended December 31,								Change
		2022				2021				$
United States		$	6,261,000			$	6,403,000			$	(142,000	)
International			2,077,000				1,351,000				726,000
Total		$	8,338,000			$	7,754,000			$	584,000